Results 191 to 200 of about 3,138,389 (246)
The WHO Classification of Genetic Tumour Syndromes: Considerations for Genetics
Clinical Genetics, Volume 110, Issue 3, Page 389-401, September 2026.The WHO Classification of Tumours underpins the diagnosis of neoplastic conditions. The new WHO classification of genetic tumour syndromes (GTS) provides international standards for their diagnosis. This diagram highlights the chromosomal distribution of the genes involved in the GTS covered in this classification.
Ian A. Cree +18 more
wiley +1 more source
Cytopathology, Volume 37, Issue 5, Page 509-516, September 2026.This quality assurance project confirms that thyroid FNAC is a reliable tool for assessing the risk of malignancy (ROM), with ROM rates aligning with published data. However, cytology team changes can reveal interobserver variability and shift category distribution and malignancy rates, underlining the need for ongoing quality assurance and training ...
Pauline Kuerten +5 more
wiley +1 more source
The Kaohsiung Journal of Medical Sciences, Volume 42, Issue 9, September 2026.
Luo‐Wei Chan +3 more
wiley +1 more source
S1 guideline sweat gland carcinoma
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 9, Page e1356-e1385, September 2026.Summary The current classification of sweat gland carcinomas is based on histomorphological characteristics and distinguishes between more than 20 entities. Most patients are older, but some subtypes also affect middle‐aged and younger patients. The majority of tumors arise de novo. Sweat gland carcinomas have nonspecific clinical features.
Mirjana Ziemer +19 more
wiley +1 more source
European Journal of Haematology, Volume 117, Issue 3, Page 642-652, September 2026.SAMHD1 regulates intracellular dNTP pools, influencing lentiviral transduction, gene therapy efficiency, and disease progression in pediatric hematological malignancies. Integrated bioinformatics and targeted strategies, including CRISPR and pharmacological inhibition, highlight its therapeutic potential.
Waseem Alzamzami
wiley +1 more source
International Journal of Urology, Volume 33, Issue 9, September 2026.ABSTRACT Objective The aim of this study was to perform a comprehensive characterization of CTSV regulation in bladder cancer (BC) and its association with clinicopathological features, prognosis, and tumor stroma modulation using multi‐omics databases.
Wallax Augusto Silva Ferreira +5 more
wiley +1 more source
When to consider an inborn error of immunity: clues for physicians
Internal Medicine Journal, Volume 56, Issue 9, Page 1488-1499, September 2026.Abstract The term inborn errors of immunity (IEIs) refers to the rapidly expanding group of genetic disorders causing dysregulation of the immune system. With improved genetic testing in recent years, the number of defined IEIs and their range of phenotypic presentations has grown vastly, with more than 550 IEIs now described.
Meera Thangarajah, Lucinda J. Berglund
wiley +1 more source
New genes involved in the neoplastic transformation of the thyroid gland [PDF]
, 2007 Pallante, Pierlorenzo
core
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Surgical Oncology Clinics of North America, 2006
In summary, PTC is common, although it rarely results in disease-specific mortality. It is being diagnosed increasingly in the subclinical phase as a result of enhanced ultrasound imaging and more aggressive surveillance of smaller thyroid nodules. US-guided FNA is the "gold-standard" for diagnosis.
Julie Ann, Sosa, Robert, Udelsman
openaire +4 more sources
In summary, PTC is common, although it rarely results in disease-specific mortality. It is being diagnosed increasingly in the subclinical phase as a result of enhanced ultrasound imaging and more aggressive surveillance of smaller thyroid nodules. US-guided FNA is the "gold-standard" for diagnosis.
Julie Ann, Sosa, Robert, Udelsman
openaire +4 more sources